Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.4297
-0.0149 (-3.35%)
At close: May 20, 2025, 4:00 PM
0.4500
+0.0203 (4.72%)
After-hours: May 20, 2025, 5:00 PM EDT
Oncolytics Biotech Stock Forecast
ONCY's stock price has decreased by -61.29% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Oncolytics Biotech stock ranges from a low of $3.00 to a high of $5.00. The average analyst price target of $4.33 forecasts a 907.68% increase in the stock price over the next year.
Price Target: $4.33 (+907.68%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 10, 2025.
Analyst Ratings
The average analyst rating for Oncolytics Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 2 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 16, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $5 → $3 | Strong Buy | Maintains | $5 → $3 | +598.16% | Mar 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +1,063.60% | Mar 10, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $6 → $5 | Buy | Maintains | $6 → $5 | +1,063.60% | Mar 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +1,063.60% | Feb 3, 2025 |
Financial Forecast
Revenue This Year
n/a
from 433.82M
Revenue Next Year
n/a
EPS This Year
-0.40
from -0.41
EPS Next Year
-0.42
from -0.40
Financial currency is CAD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 6.3M | 109.4M | ||
| Avg | n/a | 1.2M | 26.3M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 8,927.2% | ||
| Avg | - | - | 2,070.9% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.36 | -0.38 | -0.13 | ||
| Avg | -0.40 | -0.42 | -0.34 | ||
| Low | -0.46 | -0.48 | -0.45 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.